Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Magro

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Inflammatory Bowel Diseases|January 28, 2005
Reactive hepatitis in a patient with Crohn's disease successfully treated with infliximab: does tumor necrosis factor alpha play a role in reactive hepatitis?F Magro, P Pereira, F Carneiro, et al.
Acta Physiologica Scandinavica|January 29, 2005
Regional intestinal adaptations in Na+,K+-ATPase in experimental colitis and the contrasting effects of interferon-gammaF Magro, S Fraga, T Ribeiro, et al.
Acta Physiologica Scandinavica|March 20, 2004
Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-gamma upon L-DOPA uptakeF Magro, S Fraga, T Ribeiro, et al.
Digestive Diseases and Sciences|April 15, 2006
Intestinal 5-hydroxytryptamine and mast cell infiltration in rat experimental colitisF Magro, S Fraga, I Azevedo, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2018
Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' replyJ Goncalves, F Magro, S Danese, et al.
Minimally Invasive Neurosurgery : MIN|June 5, 2007
Is endoscopic third ventriculostomy an internal shunt alone?M Gangemi, F Maiuri, G Colella, et al.
Digestive Diseases and Sciences|September 25, 2004
Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel diseaseF Magro, F Araujo, P Pereira, et al.
Inflammatory Bowel Diseases|October 12, 2007
Infliximab-induced lupus-like syndrome associated with autoimmune hepatitisM Marques, F Magro, H Cardoso, et al.
Dermatology (Basel, Switzerland)|October 12, 2012
Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literatureF Osório, F Magro, C Lisboa, et al.
Journal of Crohn'S & Colitis|January 29, 2011
Dysplasia surveillance in an ulcerative colitis patient: successful detection with narrow band imaging and magnificationS Rodrigues, P Pereira, F Magro, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Inflammatory Bowel Diseases|January 28, 2005
Reactive hepatitis in a patient with Crohn's disease successfully treated with infliximab: does tumor necrosis factor alpha play a role in reactive hepatitis?F Magro, P Pereira, F Carneiro, et al.
Acta Physiologica Scandinavica|January 29, 2005
Regional intestinal adaptations in Na+,K+-ATPase in experimental colitis and the contrasting effects of interferon-gammaF Magro, S Fraga, T Ribeiro, et al.
Acta Physiologica Scandinavica|March 20, 2004
Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-gamma upon L-DOPA uptakeF Magro, S Fraga, T Ribeiro, et al.
Digestive Diseases and Sciences|April 15, 2006
Intestinal 5-hydroxytryptamine and mast cell infiltration in rat experimental colitisF Magro, S Fraga, I Azevedo, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2018
Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' replyJ Goncalves, F Magro, S Danese, et al.
Minimally Invasive Neurosurgery : MIN|June 5, 2007
Is endoscopic third ventriculostomy an internal shunt alone?M Gangemi, F Maiuri, G Colella, et al.
Digestive Diseases and Sciences|September 25, 2004
Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel diseaseF Magro, F Araujo, P Pereira, et al.
Inflammatory Bowel Diseases|October 12, 2007
Infliximab-induced lupus-like syndrome associated with autoimmune hepatitisM Marques, F Magro, H Cardoso, et al.
Dermatology (Basel, Switzerland)|October 12, 2012
Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literatureF Osório, F Magro, C Lisboa, et al.
Journal of Crohn'S & Colitis|January 29, 2011
Dysplasia surveillance in an ulcerative colitis patient: successful detection with narrow band imaging and magnificationS Rodrigues, P Pereira, F Magro, et al.
Pageof 5